Bis-pyranobenzoquinones as a New Family of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in Mammalian Cells and the Protozoan ParasiteLeishmania

Journal of Medicinal Chemistry
2008.0

Abstract

We have synthesized a set of bis-pyranobenzoquinones through a direct and highly efficient approach based on a double intramolecular domino Knoevenagel hetero Diels-Alder reaction. These bis-pyranobenzoquinone derivatives are compounds whose skeletons have similarities to those of some anticancerous and leishmanicidal drugs. Considering that these drugs are substrates for some members of the ATP-binding cassette (ABC) family of proteins that confers a multidrug resistance (MDR) phenotype, we have carried out the biological evaluation of 20 bis-pyranobenzoquinones as modulators of the MDR phenotype in mammalian cell lines overexpressing P-glycoprotein, MRP1, or BCRP. Moreover, we also tested some of these compounds as potential MDR modulators in a Leishmania tropica line overexpressing a P-glycoprotein-like transporter. Compounds 9 and 10 are, in this work, the most promising reversal agents of MDR in human cancer cell lines, while compounds 4 and 20 showed potent reversal activity of MDR phenotype in the protozoan parasite Leishmania.

Knowledge Graph

Similar Paper

Bis-pyranobenzoquinones as a New Family of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in Mammalian Cells and the Protozoan ParasiteLeishmania
Journal of Medicinal Chemistry 2008.0
Synthesis and primary evaluation of quinoxalinone derivatives as potent modulators of multidrug resistance
Medicinal Chemistry Research 2009.0
Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer
Journal of Asian Natural Products Research 2012.0
Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents
European Journal of Medicinal Chemistry 2016.0
Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents
European Journal of Medicinal Chemistry 2018.0
Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo
Biochemical and Biophysical Research Communications 2004.0
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity
Bioorganic & Medicinal Chemistry 2010.0
New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance
Bioorganic & Medicinal Chemistry 2007.0
Novel Multidrug Resistance Reversal Agents
Journal of Medicinal Chemistry 1999.0
Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance
European Journal of Medicinal Chemistry 2019.0